Mahoney Michael F's Form 4 filing
Boston Scientific Corp (BSX) · filed Nov 7, 2024
- Accession no.
- 0001225208-24-009728
- Filed
- Nov 7, 2024
- Trade date
- Nov 5, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $13.8M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mahoney Michael FCIK 0001533022 | Director, Officer (Chairman, President & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 5, 2024 | Common Stock | MOption exerciseAcquired | +56,211 | $17.26 | +$970,201.86 | 1,628,307 | Direct | |
| Nov 5, 2024 | Common Stock | MOption exerciseAcquired | +55,676 | $16.31 | +$908,075.56 | 1,683,983 | Direct | |
| Nov 5, 2024 | Common Stock | SSaleDisposed | −2,596 | $85.17F2 | −$221,101.32 | 1,681,387 | Direct | |
| Nov 5, 2024 | Common Stock | SSaleDisposed | −160,182 | $84.74F3 | −$13,573,822.68 | 1,521,205 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 5, 2024 | Common Stock | MOption exerciseDisposed | −56,211 | $0.00 | $0 | 168,635 | Direct | |
| Nov 5, 2024 | Common Stock | MOption exerciseDisposed | −55,676 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $85.14 to $85.20, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $84.145 to $85.12, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.